“is kras druggable?” experts in pancreatic cancer and kras discuss tough questions
Published 7 years ago • 1.6K plays • Length 3:51Download video MP4
Download video MP3
Similar videos
-
0:41
improving outcomes in kras-mutant pancreatic cancer
-
1:00:31
navigating pancreatic cancer - new approaches and targeting kras (john strickler, md)
-
1:01
ctdna kras mutation levels and outcomes in non-resectable pancreatic cancer
-
0:51
personalized treatment approaches for patients with kras-mutant pancreatic cancer
-
0:47
why researcher channing der demands better | pancreatic cancer awareness month
-
1:45
the future of precision oncology in pancreatic cancer
-
0:48
why pancreatic cancer is so challenging | pancreatic cancer awareness month
-
45:20
voice of pancreatic cancer podcast - targeting the kras mutation for more effective cancer treatment
-
1:48
ask ruby: what is kras?
-
1:17
codebreak100: assessing sotorasib in patients with kras p.g12c-mutant pancreatic cancer
-
2:42
assessing the heterogeneity of kras-mutant pancreatic adenocarcinomas
-
1:14
kras mutations and cancer
-
28:30
dr. gius - sirt2 regulation of kras is an early event in pancreas carcinogenesis
-
5:17
mutant p53 and oncogenic kras drive metastasis in pancreatic cancer
-
1:00:48
antonio baines - oncoproteins k ras and pim kinases as molecular targets in pancreatic cancer
-
4:46
dr viale speaks on the role of oncogenic k-ras in cancer stem cells in pancreatic tumors
-
1:14
ask unmc! am i at a higher risk for pancreatic cancer now that i have diabetes?
-
30:44
ask the expert: pancreatic cancer
-
4:09
a new era in targeting kras